AVEG 008

A Phase I Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination with Subunit Recombinant HIV Envelope Vaccines

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID) July 03, 1992
HIVAC-1e Env gp160 B
HIVAC-1e Viral Vector - Pox
USA 56